Infection-induced seroconversion and seroprevalence of SARS-CoV-2 among a cohort of children and youth in Montreal, Canada
© 2023 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd..
The EnCORE study is a prospective serology study of SARS-CoV-2 in a cohort of children from Montreal, Canada. Based on data from our fourth round of data collection (May-October 2022), we estimated SARS-CoV-2 seroprevalence and seroconversion. Using multivariable regression, we identified factors associated with seroconversion. Our results show that previously seronegative children were approximately 9-12 times more likely to seroconvert during the early Omicron-dominant period compared to pre-Omicron rounds. Unlike the pre-Omicron rounds, the adjusted rate of seroconversion among 2- to 4-year-olds was higher than older age groups. As seen previously, higher seroconversion rates were associated with ethnic/racial minority status.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
---|---|
Enthalten in: |
Influenza and other respiratory viruses - 17(2023), 8 vom: 22. Aug., Seite e13186 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zinszer, Kate [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adolescents |
---|
Anmerkungen: |
Date Completed 29.08.2023 Date Revised 06.11.2023 published: Electronic-eCollection Citation Status MEDLINE |
---|
doi: |
10.1111/irv.13186 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM361362137 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM361362137 | ||
003 | DE-627 | ||
005 | 20231226084957.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/irv.13186 |2 doi | |
028 | 5 | 2 | |a pubmed24n1204.xml |
035 | |a (DE-627)NLM361362137 | ||
035 | |a (NLM)37638094 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zinszer, Kate |e verfasserin |4 aut | |
245 | 1 | 0 | |a Infection-induced seroconversion and seroprevalence of SARS-CoV-2 among a cohort of children and youth in Montreal, Canada |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.08.2023 | ||
500 | |a Date Revised 06.11.2023 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd. | ||
520 | |a The EnCORE study is a prospective serology study of SARS-CoV-2 in a cohort of children from Montreal, Canada. Based on data from our fourth round of data collection (May-October 2022), we estimated SARS-CoV-2 seroprevalence and seroconversion. Using multivariable regression, we identified factors associated with seroconversion. Our results show that previously seronegative children were approximately 9-12 times more likely to seroconvert during the early Omicron-dominant period compared to pre-Omicron rounds. Unlike the pre-Omicron rounds, the adjusted rate of seroconversion among 2- to 4-year-olds was higher than older age groups. As seen previously, higher seroconversion rates were associated with ethnic/racial minority status | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Canada | |
650 | 4 | |a SARS‐CoV‐2 | |
650 | 4 | |a adolescents | |
650 | 4 | |a children | |
650 | 4 | |a seroconversion | |
650 | 4 | |a seroprevalence | |
700 | 1 | |a Charland, Katia |e verfasserin |4 aut | |
700 | 1 | |a Pierce, Laura |e verfasserin |4 aut | |
700 | 1 | |a Saucier, Adrien |e verfasserin |4 aut | |
700 | 1 | |a Hamelin, Marie-Ève |e verfasserin |4 aut | |
700 | 1 | |a Da Torre, Margot Barbosa |e verfasserin |4 aut | |
700 | 1 | |a Carbonneau, Julie |e verfasserin |4 aut | |
700 | 1 | |a Nguyen, Cat Tuong |e verfasserin |4 aut | |
700 | 1 | |a De Serres, Gaston |e verfasserin |4 aut | |
700 | 1 | |a Papenburg, Jesse |e verfasserin |4 aut | |
700 | 1 | |a Boivin, Guy |e verfasserin |4 aut | |
700 | 1 | |a Quach, Caroline |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Influenza and other respiratory viruses |d 2007 |g 17(2023), 8 vom: 22. Aug., Seite e13186 |w (DE-627)NLM176605215 |x 1750-2659 |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2023 |g number:8 |g day:22 |g month:08 |g pages:e13186 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/irv.13186 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 17 |j 2023 |e 8 |b 22 |c 08 |h e13186 |